Featured Research

from universities, journals, and other organizations

Environmental risk assessment of pharmaceuticals inadequate, Swedish researchers says

Date:
October 18, 2010
Source:
University of Gothenburg
Summary:
The strategies used to assess the environmental risks posed by pharmaceuticals are not enough to protect natural microbial communities, says a researcher from Sweden who is calling for better environmental risk assessments.

The strategies used to assess the environmental risks posed by pharmaceuticals are not enough to protect natural microbial communities, reveals a researcher from the University of Gothenburg (Sweden) who is calling for better environmental risk assessments.

Related Articles


"Above all, we need to include the combined effects of different drugs to reflect the situation in nature as it really is," says Sara Brosché from the Department of Plant and Environmental Sciences at the University of Gothenburg.

Modern medicine relies on pharmaceuticals for the treatment of practically everything, from headaches to cancer. The active substances in the drugs we take do not disappear into the body but are gradually secreted in urine and faeces. They then enter the sewerage system, and small amounts make it through the entire sewage treatment process.

Small quantities of pharmaceuticals are nowadays found in most aquatic environments, from groundwater to seawater. The highest concentrations are in the effluent from sewage treatment plants, often in the form of a cocktail of many different drugs. Once out in nature, these drug residues continue to affect living creatures. This applies particularly to antimicrobial agents such as antibiotics and antifungals, which are designed to kill microorganisms whether they are "bad" and cause infection, or "good" and serve important functions in nature.

"I saw effects on bacteria from the antibiotic chlortetracycline even at the concentrations shown in scientific publications to be present in the effluent from sewage treatment plants. Although chlortetracycline is no longer used in Sweden, many antibiotics from the same class are still in use."

In her research, Brosché has looked primarily at the combined effects of pharmaceuticals, as a cocktail of toxic substances will generally have a greater effect than the sum of its constituent parts. Her results show that although the levels of drugs normally seen in the environment are low, they are not without their risks.

"When five pharmaceuticals and personal care products (fluoxetine, propranolol, zinc pyritione, clotrimazole and triclosan) were mixed together at concentrations which did not have any significant effect individually, the mixture had an almost 30% effect on microalgae."

Brosché has also studied the high levels of antibiotics in effluents from pharmaceutical production in India. When microbial communities were exposed to this effluent, they rapidly developed increased tolerance to the antibiotic ciprofloxacin.


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "Environmental risk assessment of pharmaceuticals inadequate, Swedish researchers says." ScienceDaily. ScienceDaily, 18 October 2010. <www.sciencedaily.com/releases/2010/10/101018074608.htm>.
University of Gothenburg. (2010, October 18). Environmental risk assessment of pharmaceuticals inadequate, Swedish researchers says. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2010/10/101018074608.htm
University of Gothenburg. "Environmental risk assessment of pharmaceuticals inadequate, Swedish researchers says." ScienceDaily. www.sciencedaily.com/releases/2010/10/101018074608.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins